Matej Mikulic
Research expert covering health, pharma & medtech
Pharmaceutical and biotech M&A deals – statistics & facts
Mergers and acquisitions (M&As) in the biopharmaceutical industry play a more important role than in almost any other industry. Many of the big pharmaceutical companies are more than 100 years old, and over this long history, M&A activity has been vital to their survival or reinvention. M&A deals in the biopharma industry can be divided mostly into two types: mega-mergers and bolt-on acquisitions. Mega-mergers describe when a large company merges with or acquires another big player; a bolt-on acquisition is when a large company acquires a small or mid-sized company.
